{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:15:15Z","timestamp":1776338115683,"version":"3.51.2"},"reference-count":119,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Cardiac arrest is a way of demise of patients who are affected by heart failure (HF), being more frequent in those with HF with a reduced left ventricular ejection fraction (HFrEF), and is, as such, responsible for 30\u201350% of cardiac death. Specific data on the risk of sudden cardiac death (SCD) related to HF with a preserved ejection fraction (HFpEF) and HF with a mildly reduced ejection fraction (HFmrEF) are lacking, as well as data regarding ventricular arrhythmias in this population. Considering the 0.3% person\/year incidence rate of investigator-reported ventricular tachycardia (VT) and ventricular fibrillation (VF), the rate of SCD in the analyzed population seems to be 1.3% per year. Age, gender, history of diabetes and myocardial infarction, left bundle branch block (LBBB) on electrocardiogram (ECG), and a natural logarithm of N-terminal pro B-type natriuretic peptide (NT-proBNP), identified a subgroup of HFpEF patients with a higher risk (5-year cumulative incidence of 11%) of sudden death (SD). In HFpEF patients, both glifozins and finerenone did not demonstrate a beneficial effect on SCD incidence in comparison to placebo. A significantly lower rate of SCD emerged in patients who were treated with dapaglifozin (10 vs. 26 pts) among patients with HF with an improved ejection fraction (HFimpEF), who were defined as patients with a previous left ventricular ejection fraction (LVEF) &lt; 40%. Promising methods discussed include cardiac magnetic resonance, myocardial scintigraphy, genetic assessment, and electrophysiologic studies for predicting SCD in those patients. In conclusion, arrhythmic SCD in HFpEF patients should not be considered merely as an effect of VT\/VF; bradyarrhythmia is probably more frequent and dangerous. The effects of drugs in preventing SCD in HFpEF have not been demonstrated yet.<\/jats:p>","DOI":"10.3390\/jcm15083041","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:14:46Z","timestamp":1776334486000},"page":"3041","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting Sudden Cardiac Death in Heart Failure with Mildly Reduced\/Preserved Left Ventricular Ejection Fraction: A Clinical Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8138-5189","authenticated-orcid":false,"given":"Mauro","family":"Feola","sequence":"first","affiliation":[{"name":"Cardiology Division, Regina Montis Regalis Hospital, Azienda Sanitaria Locale Cuneo 1 (ASLCN1), 12084 Mondov\u00ec, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2106-0884","authenticated-orcid":false,"given":"Federico","family":"Landra","sequence":"additional","affiliation":[{"name":"Cardiology Division, Regina Montis Regalis Hospital, Azienda Sanitaria Locale Cuneo 1 (ASLCN1), 12084 Mondov\u00ec, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosimo Angelo","family":"Greco","sequence":"additional","affiliation":[{"name":"Cardiology Unit, I. Veris Delli Ponti Hospital, Azienda Sanitaria Locale di Lecce, 73020 Scorrano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1777-2045","authenticated-orcid":false,"given":"Roberto","family":"Lorusso","sequence":"additional","affiliation":[{"name":"Cardiothoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre, 6202 AZ Maastrict, The Netherlands"},{"name":"Cardiovascular Research Institute Maastricht, Maastrict University, 6202 AZ Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Ruocco","sequence":"additional","affiliation":[{"name":"Cardiology Unit, I. Veris Delli Ponti Hospital, Azienda Sanitaria Locale di Lecce, 73020 Scorrano, Italy"},{"name":"Cardiothoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre, 6202 AZ Maastrict, The Netherlands"},{"name":"Cardiovascular Research Institute Maastricht, Maastrict University, 6202 AZ Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/01.CIR.72.4.681","article-title":"Sudden unexpected death in patients with congestive heart failure: A second frontier","volume":"72","author":"Packer","year":"1985","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMcp0909392","article-title":"Systolic heart failure","volume":"362","author":"McMurray","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/ejhf.1995","article-title":"Addressing the sudden cardiac death conundrum in heart failure with preserved ejection fraction: Do we need a microscope or a telescope?","volume":"22","author":"Grazette","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/eurheartj\/ehz553","article-title":"What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?","volume":"41","author":"Packer","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609758","article-title":"Declining Risk of Sudden Death in Heart Failure","volume":"377","author":"Shen","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacc.2005.11.045","article-title":"Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: Two-year findings from the Oregon Sudden Unexpected Death Study","volume":"47","author":"Stecker","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/eurheartj\/ehac801","article-title":"Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction","volume":"44","author":"Curtain","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/eurheartj\/ehad001","article-title":"Ventricular arrhythmias and sudden cardiac death in heart failure with mildly reduced or preserved ejection fraction: Knowledge gaps","volume":"44","author":"Waldmann","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.hrthm.2020.05.038","article-title":"Sudden cardiac arrest with shockable rhythm in patients with heart failure","volume":"17","author":"Woolcott","year":"2020","journal-title":"Heart Rhythm"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/ejhf.1970","article-title":"Ventricular tachyarrhythmia detection by implantable loop recording in patients with heart failure and preserved ejection fraction: The VIP-HF study","volume":"22","author":"Gorter","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0735-1097(20)31062-7","article-title":"Rhythm disturbances in patients with heart failure and preserved ejection fraction","volume":"75","author":"Cho","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jacc.2016.10.078","article-title":"Mode of Death in Heart Failure with Preserved Ejection Fraction","volume":"69","author":"Vaduganathan","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.resuscitation.2007.08.022","article-title":"Beta-blocker use and the changing epidemiology of out-of-hospital cardiac arrest rhythms","volume":"76","author":"Youngquist","year":"2008","journal-title":"Resuscitation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.hroo.2021.10.007","article-title":"Arrhythmic causes of in-hospital cardiac arrest among patients with heart failure with preserved ejection fraction","volume":"2","author":"Hooks","year":"2021","journal-title":"Heart Rhythm O2"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.hrthm.2024.12.006","article-title":"Implications of primary bradycardia in patients with hypertrophic cardiomyopathy","volume":"22","author":"Liu","year":"2025","journal-title":"Heart Rhythm"},{"key":"ref_16","first-page":"102527","article-title":"Incidence of Cardiac Arrhythmias Identified by Insertable Cardiac Monitors in Patients with Symptomatic Heart Failure","volume":"13","author":"Kahwash","year":"2025","journal-title":"J. Am. Coll. Cardiol. Heart Fail."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/ejhf.172","article-title":"A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction","volume":"16","author":"Adabag","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.hrthm.2019.12.009","article-title":"Sudden cardiac death risk prediction in heart failure with preserved ejection fraction","volume":"17","author":"Adabag","year":"2020","journal-title":"Heart Rhythm"},{"key":"ref_19","first-page":"653","article-title":"Sudden Death in Heart Failure with Preserved Ejection Fraction: A Competing Risks Analysis From the TOPCAT Trial","volume":"6","author":"Vaduganathan","year":"2018","journal-title":"J. Am. Coll. Cardiol. Heart Fail."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/jamacardio.2022.3736","article-title":"Effect of Dapagliflozin on Cause-Specific Mortality in Patients with Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER","volume":"7","author":"Desai","year":"2022","journal-title":"JAMA Cardiol."},{"key":"ref_21","first-page":"221","article-title":"The association between atrial fibrillation and sudden cardiac death: The relevance of heart failure","volume":"2","author":"Reinier","year":"2014","journal-title":"J. Am. Coll. Cardiol. Heart Fail."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/CIRCEP.112.977777","article-title":"Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy","volume":"6","author":"Okin","year":"2013","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10741-021-10134-5","article-title":"Left ventricular hypertrophy and sudden cardiac death","volume":"27","author":"Giamouzis","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"ref_24","first-page":"1146","article-title":"Left-ventricular geometry and risk of sudden cardiac arrest in patients with preserved or moderately reduced left-ventricular ejection fraction","volume":"19","author":"Aro","year":"2017","journal-title":"Europace"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.amjcard.2020.04.038","article-title":"Cardiac Function and Sudden Cardiac Death in Heart Failure with Preserved Ejection Fraction (from the TOPCAT Trial)","volume":"129","author":"Kalra","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e002763","DOI":"10.1161\/CIRCHEARTFAILURE.115.002763","article-title":"Prognostic Relevance of Left Atrial Dysfunction in Heart Failure with Preserved Ejection Fraction","volume":"9","author":"Santos","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e004431","DOI":"10.1161\/CIRCIMAGING.115.004431","article-title":"Echocardiographic Predictors of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study and Cardiovascular Health Study","volume":"9","author":"Konety","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ejhf.1694","article-title":"Predictors of sudden cardiac death in high-risk patients following a myocardial infarction","volume":"22","author":"Docherty","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_29","first-page":"2869","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: A plea for proper phenotyping and further research","volume":"38","author":"Hoeper","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/eurheartj\/ehy809","article-title":"Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction","volume":"40","author":"Obokata","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e006091","DOI":"10.1161\/CIRCEP.117.006091","article-title":"Right Ventricular Dysfunction and Long-Term Risk of Sudden Cardiac Death in Patients With and Without Severe Left Ventricular Dysfunction","volume":"11","author":"Naksuk","year":"2018","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.hrthm.2019.10.021","article-title":"An association between right ventricular dysfunction and sudden cardiac death","volume":"17","author":"Pandat","year":"2020","journal-title":"Heart Rhythm"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/jce.15894","article-title":"SGLT2 inhibitors reduce sudden cardiac death risk in heart failure: Meta-analysis of randomized clinical trials","volume":"34","author":"Oates","year":"2023","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/europace\/euab177","article-title":"Association between sodium-glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: A meta-analysis of randomized controlled trials","volume":"24","author":"Sfairopoulos","year":"2022","journal-title":"Europace"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Matteucci, A., Pandozi, C., Bonanni, M., Mariani, M.V., Sgarra, L., Nesti, L., Pierucci, N., La Fazia, V.M., Lavalle, C., and Nardi, F. (2025). Impact of Empagliflozin and Dapagliflozin on Sudden Cardiac Death: A Systematic Review and Meta-Analysis of Adjudicated Randomized Evidence. Heart Rhythm, in press.","DOI":"10.1016\/j.hrthm.2025.09.023"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.hrthm.2021.03.028","article-title":"Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials","volume":"18","author":"Fernandes","year":"2021","journal-title":"Heart Rhythm"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13643-025-02766-7","article-title":"Redefining outcomes of ventricular arrhythmia for SGLT2 inhibitor medication in heart failure patients: A meta-analysis of randomized controlled trials","volume":"14","author":"Lin","year":"2025","journal-title":"Syst. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Sato, T., Kouzu, H., Yano, T., Sakuma, I., Furuhashi, M., and Tohse, N. (2023). Potential favorable action of sodium-glucose cotransporter-2 inhibitors on sudden cardiac death: A brief overview. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1159953"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1093\/eurheartj\/ehab560","article-title":"Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF","volume":"42","author":"Curtain","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ejhf.1536","article-title":"Evaluation of the effect of sodium-glucose co- transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: Rationale for and design of the EMPEROR-Reduced trial","volume":"21","author":"Packer","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/jamacardio.2023.5318","article-title":"Dapagliflozin and Mode of Death in Heart Failure with Improved Ejection Fraction: A Post Hoc Analysis of the DELIVER Trial","volume":"9","author":"Vardeny","year":"2024","journal-title":"JAMA Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in Heart Failure with a Preserved Ejection Fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.120.051898","article-title":"Finerenone and Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes","volume":"143","author":"Filippatos","year":"2021","journal-title":"Circulation"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_47","first-page":"102497","article-title":"Efficacy and Safety of Finerenone in Heart Failure with Preserved Ejection Fraction: A FINE- HEART Analysis","volume":"13","author":"Ostrominski","year":"2025","journal-title":"J. Am. Coll. Cardiol. Heart Fail."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/s41591-024-03264-4","article-title":"Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes","volume":"30","author":"Vaduganathan","year":"2024","journal-title":"Nat. Med."},{"key":"ref_49","first-page":"1221","article-title":"Myocardial Tissue Characterization and Fibrosis by Imaging","volume":"13","author":"Karamitsos","year":"2020","journal-title":"J. Am. Coll. Cardiol. Cardiovasc. Imaging"},{"key":"ref_50","first-page":"2223","article-title":"Sudden Cardiac Death in Ischemic Heart Disease: From Imaging Arrhythmogenic Substrate to Guiding Therapies","volume":"13","author":"Benz","year":"2020","journal-title":"J. Am. Coll. Cardiol. Cardiovasc. Imaging"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.hrthm.2015.05.026","article-title":"Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy","volume":"12","author":"Piers","year":"2015","journal-title":"Heart Rhythm"},{"key":"ref_52","first-page":"28","article-title":"Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis","volume":"5","author":"Anguera","year":"2017","journal-title":"J. Am. Coll. Cardiol. Heart Fail."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.jacc.2021.04.030","article-title":"Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients with Nonischemic Dilated Cardiomyopathy","volume":"77","author":"Brown","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/europace\/euab275","article-title":"Cardiovascular magnetic resonance determinants of ventricular arrhythmic events after myocardial infarction","volume":"24","author":"Penela","year":"2022","journal-title":"Europace"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e006709","DOI":"10.1161\/CIRCIMAGING.117.006709","article-title":"Diagnosis and Prognosis in Sudden Cardiac Arrest Survivors Without Coronary Artery Disease: Utility of a Clinical Approach Using Cardiac Magnetic Resonance Imaging","volume":"10","author":"Rodrigues","year":"2017","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/CIRCULATIONAHA.120.048477","article-title":"Relationship of LVEF and Myocardial Scar to Long-Term Mortality Risk and Mode of Death in Patients with Nonischemic Cardiomyopathy","volume":"143","author":"Klem","year":"2021","journal-title":"Circulation"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/CIRCIMAGING.113.001768","article-title":"Prevalence of myocardial fibrosis patterns in patients with systolic dysfunction: Prognostic significance for the prediction of sudden cardiac arrest or appropriate implantable cardiac defibrillator therapy","volume":"7","author":"Almehmadi","year":"2014","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_58","first-page":"480","article-title":"Entropy as a Novel Measure of Myocardial Tissue Heterogeneity for Prediction of Ventricular Arrhythmias and Mortality in Post-Infarct Patients","volume":"5","author":"Androulakis","year":"2019","journal-title":"J. Am. Coll. Cardiol. Clin. Electrophysiol."},{"key":"ref_59","first-page":"1359","article-title":"Substrates of Scar-Related Ventricular Arrhythmia in Patients with Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study","volume":"16","author":"Francia","year":"2023","journal-title":"J. Am. Coll. Cardiol. Cardiovasc. Imaging"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/CIRCEP.111.961946","article-title":"Integration of 3D electroanatomic maps and magnetic resonance scar characterization into the navigation system to guide ventricular tachycardia ablation","volume":"4","author":"Andreu","year":"2011","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/eurheartj\/eht510","article-title":"Usefulness of contrast-enhanced cardiac magnetic resonance in identifying the ventricular arrhythmia substrate and the approach needed for ablation","volume":"35","author":"Andreu","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/jce.12963","article-title":"Image Integration to Guide Catheter Ablation in Scar-Related Ventricular Tachycardia","volume":"27","author":"Yamashita","year":"2016","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_63","first-page":"436","article-title":"Cardiac Magnetic Resonance-Guided Ventricular Tachycardia Substrate Ablation","volume":"6","author":"Penela","year":"2020","journal-title":"J. Am. Coll. Cardiol. Clin. Electrophysiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"euae244","DOI":"10.1093\/europace\/euae244","article-title":"Novel systematic processing of cardiac magnetic resonance imaging identifies target regions associated with infarct-related ventricular tachycardia","volume":"26","author":"Quintanilla","year":"2024","journal-title":"Europace"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"euaf051","DOI":"10.1093\/europace\/euaf051","article-title":"Outcomes of ventricular tachycardia ablation facilitated by pre-procedural cardiac imaging-derived scar characterization: A prospective multi-centre international registry","volume":"27","author":"Penela","year":"2025","journal-title":"Europace"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e005277","DOI":"10.1161\/CIRCIMAGING.116.005277","article-title":"Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure with Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study","volume":"9","author":"Duca","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jamacardio.2017.2511","article-title":"Temporal Relation Between Myocardial Fibrosis and Heart Failure with Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome","volume":"2","author":"Schelbert","year":"2017","journal-title":"JAMA Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e002613","DOI":"10.1161\/JAHA.115.002613","article-title":"Myocardial Fibrosis Quantified by Extracellular Volume Is Associated with Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage","volume":"4","author":"Schelbert","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_69","first-page":"2291","article-title":"Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure with Preserved Ejection Fraction","volume":"12","author":"Kanagala","year":"2019","journal-title":"J. Am. Coll. Cardiol. Cardiovasc. Imaging"},{"key":"ref_70","first-page":"44","article-title":"Extracellular Volume Associates with Outcomes More Strongly Than Native or Post-Contrast Myocardial T1","volume":"13","author":"Treibel","year":"2020","journal-title":"J. Am. Coll. Cardiol. Cardiovasc. Imaging"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/ehjci\/jeac204","article-title":"Cardiovascular magnetic resonance phenotyping of heart failure with mildly reduced ejection fraction","volume":"24","author":"Brown","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ehjci\/jeac142","article-title":"Extracellular volume fraction improves risk-stratification for ventricular arrhythmias and sudden death in non-ischaemic cardiomyopathy","volume":"24","author":"Brown","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.hrthm.2023.10.019","article-title":"Up digital and personal: How heart digital twins can transform heart patient care","volume":"21","author":"Trayanova","year":"2024","journal-title":"Heart Rhythm"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e222239","DOI":"10.1148\/radiol.222239","article-title":"AI Cardiac MRI Scar Analysis Aids Prediction of Major Arrhythmic Events in the Multicenter DERIVATE Registry","volume":"307","author":"Ghanbari","year":"2023","journal-title":"Radiology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.hrthm.2024.09.003","article-title":"Prediction of sudden cardiac death using artificial intelligence: Current status and future directions","volume":"22","author":"Kolk","year":"2025","journal-title":"Heart Rhythm"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s44161-022-00041-9","article-title":"Arrhythmic sudden death survival prediction using deep learning analysis of scarring in the heart","volume":"1","author":"Popescu","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"iv60","DOI":"10.1093\/europace\/euw351","article-title":"A feasibility study of arrhythmia risk prediction in patients with myocardial infarction and preserved ejection fraction","volume":"18","author":"Deng","year":"2016","journal-title":"Europace"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s44161-022-00133-6","article-title":"Fat infiltration in the infarcted heart as a paradigm for ventricular arrhythmias","volume":"1","author":"Sung","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_79","first-page":"1235","article-title":"Lipomatous Metaplasia Facilitates Slow Conduction in Critical Ventricular Tachycardia Corridors Within Postinfarct Myocardium","volume":"9","author":"Xu","year":"2023","journal-title":"J. Am. Coll. Cardiol. Clin Electrophysiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.hrthm.2023.07.066","article-title":"Lipomatous metaplasia as the most reliable computed tomography predictor for functional substrate localization in scar-related ventricular tachycardia","volume":"20","author":"Parollo","year":"2023","journal-title":"Heart Rhythm"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jelectrocard.2022.09.004","article-title":"Arrhythmia in hypertrophic cardiomyopathy: Risk prediction using contrast enhanced MRI, T1 mapping, and personalized virtual heart technology","volume":"74","author":"Prakosa","year":"2022","journal-title":"J. Electrocardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/01.CIR.88.1.172","article-title":"Correlation between scintigraphic evidence of regional sympathetic neuronal dysfunction and ventricular refractoriness in the human heart","volume":"88","author":"Calkins","year":"1993","journal-title":"Circulation"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCIMAGING.108.782433","article-title":"123I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: A prospective multicenter pilot study","volume":"1","author":"Bax","year":"2008","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1067\/mnc.2003.2","article-title":"I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator","volume":"10","author":"Arora","year":"2003","journal-title":"J. Nucl. Cardiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.jacc.2009.12.066","article-title":"Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients","volume":"55","author":"Boogers","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1253\/circj.66.537","article-title":"Prognostic value of repeated 123I-metaiodobenzylguanidine imaging in patients with dilated cardiomyopathy with congestive heart failure before and after optimized treatments-comparison with neurohumoral factors","volume":"66","author":"Matsui","year":"2002","journal-title":"Circ. J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00006231-199906000-00007","article-title":"Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy","volume":"20","author":"Momose","year":"1999","journal-title":"Nucl. Med. Commun."},{"key":"ref_88","first-page":"1757","article-title":"Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death","volume":"42","author":"Wakabayashi","year":"2001","journal-title":"J. Nucl. Med."},{"key":"ref_89","first-page":"471","article-title":"Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure","volume":"33","author":"Merlet","year":"1992","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"ref_90","first-page":"917","article-title":"Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy","volume":"40","author":"Merlet","year":"1999","journal-title":"J. Nucl. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/hrt.2006.094524","article-title":"Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging","volume":"93","author":"Kioka","year":"2007","journal-title":"Heart"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jacc.2008.10.025","article-title":"Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: Results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion","volume":"53","author":"Tamaki","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1007\/s00259-026-07776-8","article-title":"Stratifying risk of heart failure death and arrhythmic events: A 123I-meta-iodobenzylguanidine-based multinomial logistic model","volume":"53","author":"Nakajima","year":"2026","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_95","first-page":"655","article-title":"Prognostic Significance of Cardiac 123I-MIBG SPECT Imaging in Heart Failure Patients with Preserved Ejection Fraction","volume":"15","author":"Seo","year":"2022","journal-title":"J. Am. Coll. Cardiol. Cardiovasc. Imaging"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat. Genet."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1161\/ATVBAHA.120.314856","article-title":"Genome-Wide Polygenic Score, Clinical Risk Factors, and Long-Term Trajectories of Coronary Artery Disease","volume":"40","author":"Hindy","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jacc.2022.05.049","article-title":"Polygenic Risk Score Predicts Sudden Death in Patients with Coronary Disease and Preserved Systolic Function","volume":"80","author":"Sandhu","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC Mutations Are Associated with High-Risk Dilated and Arrhythmogenic Cardiomyopathies","volume":"68","author":"Cuenca","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e005371","DOI":"10.1161\/CIRCHEARTFAILURE.118.005371","article-title":"Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy","volume":"12","author":"Parikh","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy","volume":"141","author":"Smith","year":"2020","journal-title":"Circulation"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","article-title":"Outcome in phospholamban R14del carriers: Results of a large multicentre cohort study","volume":"7","author":"Groeneweg","year":"2014","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","article-title":"2017 AHA\/ACC\/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"72","author":"Stevenson","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A randomized study of the prevention of sudden death in patients with coronary artery disease","volume":"341","author":"Buxton","year":"1999","journal-title":"N Engl. J. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/ehz260","article-title":"Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: The PRESERVE EF study","volume":"40","author":"Gatzoulis","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ijcard.2014.08.068","article-title":"Prognostic value of programmed ventricular stimulation for sudden death in selected high risk patients with structural heart disease and preserved systolic function","volume":"176","author":"Gatzoulis","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/eurheartj\/ehz570","article-title":"High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy","volume":"41","author":"Chivulescu","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.hrthm.2025.05.014","article-title":"Programmed ventricular stimulation for risk stratification in patients with myocardial scarring and mildly reduced or preserved ejection fraction","volume":"22","author":"Soris","year":"2025","journal-title":"Heart Rhythm"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur. Heart J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/jce.12751","article-title":"Catheter Ablation of Ventricular Tachycardia as the First-Line Therapy in Patients with Coronary Artery Disease and Preserved Left Ventricular Systolic Function: Long-Term Results","volume":"26","author":"Clemens","year":"2015","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/eurheartj\/ehu040","article-title":"Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%","volume":"35","author":"Maury","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.113.003063","article-title":"Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: Results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study","volume":"129","author":"Dinov","year":"2014","journal-title":"Circulation"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e004357","DOI":"10.1161\/CIRCEP.116.004357","article-title":"Multicenter Experience with Catheter Ablation for Ventricular Tachycardia in Lamin A\/C Cardiomyopathy","volume":"9","author":"Kumar","year":"2016","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_116","unstructured":"(2024, October 24). International Multicenter Project Comparing Radiofrequency Ablation Versus Implantable Defibrillator After Well-Tolerated Ventricular Tachycardia in Ischemic Heart Disease with Minimally Impaired Ejection Fraction (VIVA), Available online: https:\/\/clinicaltrials.gov\/study\/NCT06294028?cond=NCT06294028&rank=1."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC Guidelines on cardiac pacing cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ejhf.3150","article-title":"Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)","volume":"26","author":"Mullens","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis treatment of acute chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/8\/3041\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:30:54Z","timestamp":1776335454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/8\/3041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":119,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["jcm15083041"],"URL":"https:\/\/doi.org\/10.3390\/jcm15083041","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]}}}